nb100-695 Search Results


vdac1  (Novus Biologicals)
93
Novus Biologicals vdac1
Vdac1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vdac1/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
vdac1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
vdac1 antibody  (Novus Biologicals)
92
Novus Biologicals vdac1 antibody
Figure 1: Protein levels of CypD and NDUFS2 relative to <t>VDAC1.</t> (a) Representative blots and quantification of relative CypD levels (n=4). (b) Representative blots and quantification of relative NDUFS2 levels (n=5). *- statistically significantly different compared to 24–26 months group.
Vdac1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vdac1 antibody/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
vdac1 antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

Image Search Results


Figure 1: Protein levels of CypD and NDUFS2 relative to VDAC1. (a) Representative blots and quantification of relative CypD levels (n=4). (b) Representative blots and quantification of relative NDUFS2 levels (n=5). *- statistically significantly different compared to 24–26 months group.

Journal: Biomedical Journal of Scientific & Technical Research

Article Title: "Age-Related Variations of the Brain Mitochondrial Permeability Transition Pore and Complex I in Response to Hypoxia"

doi: 10.26717/bjstr.2023.51.008169

Figure Lengend Snippet: Figure 1: Protein levels of CypD and NDUFS2 relative to VDAC1. (a) Representative blots and quantification of relative CypD levels (n=4). (b) Representative blots and quantification of relative NDUFS2 levels (n=5). *- statistically significantly different compared to 24–26 months group.

Article Snippet: The primary antibodies were: NDUFS2 antibody (NBP230413, Novus biologicals) diluted 1:1000 in blocking buffer (5% BSA in TBST); Cyclophilin-F Antibody (JM71-39, Novus biologicals) diluted 1:2000 in blocking buffer; and VDAC1 Antibody (SA93-03, Novus biologicals) diluted 1:2000 in blocking buffer.

Techniques: